Replies to post #17000 on Synaptogenix Inc (SNPX)

[DRK123]

Great recap—thank you. It appears this is all coming together. Exciting. And before we know it, 2022 will be around the corner, on our doorstep(s)

[Cyosol]

Thanks for the summary. If the closing price can stay above $2 I'd say the Nasdaq listing will happen in March around the same time the 10K is filed.

Diagnostic test doesn't seem to need FDA approval since it's not a medical device:

https://www.ndx-discern.com/discern/

"Disclaimer: This test was developed and its performance characteristics were determined by the Rockefeller Neuroscience Institute and SYNAPS Dx. It has not been cleared or approved by the US Food and Drug Administration. The FDA does not require this test to go through premarket FDA review. It should not be regarded as investigational or for research. This test should be interpreted in context with other clinical findings. The SYNAPS Dx’s laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing. Although these tests are highly accurate, rare diagnostic errors may occur. Possible diagnostic errors include sample mix-up, erroneous specimen identification, technical errors and clerical errors. The report from SYNAPS Dx does not represent medical advice. Any questions, suggestions, or concerns regarding interpretation of results should be forwarded to a physician skilled in interpretation of the relevant medical literature."

[InTheTrenches]

Thanks for the update from this conference, Coach.

Of all the other potential indications for Bryostatin, I'm most interested in a traumatic brain injury (TBI) treatment. Imagine a drug that can treat athletes who sustain a concussion, or soldiers returning from frontlines with TBI. An area of treatment, with unmet need, for our younger population!